86
Participants
Start Date
December 9, 2019
Primary Completion Date
December 31, 2021
Study Completion Date
December 31, 2021
Low dose tenecteplase
Intravenous (IV) tenecteplase 0.25 mg/kg (single bolus; maximum dose 25 mg)
High dose tenecteplase
Intravenous (IV) tenecteplase 0.32 mg/kg (single bolus; maximum dose 32 mg)
Huashan Hospital, Shanghai
The First Affiliated Hospital of Shanxi Medical University
OTHER
Ningbo No. 1 Hospital
OTHER
Zhejiang Province People's Hospital
UNKNOWN
Shanghai 5th People's Hospital
OTHER
Shanghai 10th People's Hospital
OTHER
Shanghai 6th People's Hospital
OTHER
The Second Affiliated Hospital of Chongqing Medical University
OTHER
The Second People's Hospital of Huai'an
OTHER
Pu'er City People's Hospital
UNKNOWN
ShuGuang Hospital
OTHER
Shanghai East Hospital
OTHER
First People's Hospital of Shenyang
OTHER
Huashan Hospital
OTHER